SECOND AMENDMENT TO SENIOR SECURED CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENT AND NOTESSenior Secured Convertible Promissory Note Purchase Agreement • June 3rd, 2011 • Amarantus BioSciences, Inc. • Retail-retail stores, nec • New York
THIS SECOND AMENDMENT TO THE SENIOR SECURED CONVERTIBLE PROMISSORY NOTE AGREEMENT AND NOTES (the "Amendment") is entered into as of May __, 2011 (the "Effective Date"), by and among Amarantus Therapeutics, Inc., a Delaware corporation (the "Company"), each of the parties (collectively the "Investors" and individually an "Investor") severally listed on the Schedule of Investors attached hereto as Exhibit A, and Seahawk Capital Partners, Inc., as collateral agent on behalf of the Investors (the "Collateral Agent").
AMARANTUS THERAPEUTICS, INC. SENIOR SECURED CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENTSenior Secured Convertible Promissory Note Purchase Agreement • June 3rd, 2011 • Amarantus BioSciences, Inc. • Retail-retail stores, nec
THIS SENIOR SECURED CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENT (the "Agreement") is entered into as of December 28, 2010 (the "Effective Date"), by and among Amarantus Therapeutics, Inc., a Delaware corporation (the "Company"), each of the parties (collectively the "Investors" and individually an "Investor") severally listed on the Schedule of Investors attached hereto as Exhibit A, and Seahawk Capital Partners, Inc., as collateral agent on behalf of the Investors (the "Collateral Agent").
AMENDMENT NO. 1 TO SENIOR SECURED CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENTSenior Secured Convertible Promissory Note Purchase Agreement • October 21st, 2013 • Kior Inc • Industrial organic chemicals • New York
This AMENDMENT NO. 1 TO SENIOR SECURED CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENT (the “Amendment”) is made as of October 20, 2013, by and among KiOR, Inc., a Delaware corporation (“KiOR”, and together with each other Subsidiary that is a party to the Purchase Agreement (as defined below) or becomes a party to the Purchase Agreement, collectively the “Company”), the Purchasers (as defined in the Purchase Agreement) and Khosla Ventures III LP as Agent.
Senior Secured Convertible Promissory NOTE PURCHASE AGREEMENTSenior Secured Convertible Promissory Note Purchase Agreement • November 13th, 2023 • 10X Capital Venture Acquisition Corp. III • Blank checks • Delaware
THIS Secured Convertible Promissory NOTE PURCHASE AGREEMENT (as amended and/or restated from time to time, this “Agreement”), is made as of October 31, 2023 by and between American Gene Technologies International Inc., a Delaware corporation (the “Company”), and each of the individuals and entities listed on Exhibit A attached to this Agreement (each an “Investor” and together the “Investors”).
AURIGA LABORATORIES, INC. SENIOR SECURED CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENTSenior Secured Convertible Promissory Note Purchase Agreement • June 13th, 2008 • Auriga Laboratories, Inc. • Pharmaceutical preparations • Delaware
This Senior Secured Convertible Promissory Note Purchase Agreement (the “Agreement”) is made as of the 9th day of June, 2008, by and between Auriga Laboratories, Inc., a Delaware corporation (the “Company”), and Prospector Capital Partners II, LLC, a Delaware limited liability company (the “Purchaser”).
ContractSenior Secured Convertible Promissory Note Purchase Agreement • May 5th, 2020 • New York
EX-10.2 6 ex10_2.htm EXHIBIT 10.2 AM Draft: 5/20/2011 SECOND AMENDMENT TO SENIOR SECURED CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENT AND NOTES THIS SECOND AMENDMENT TO THE SENIOR SECURED CONVERTIBLE PROMISSORY NOTE AGREEMENT AND NOTES (the "Amendment") is entered into as of May __, 2011 (the "Effective Date"), by and among Amarantus Therapeutics, Inc., a Delaware corporation (the "Company"), each of the parties (collectively the "Investors" and individually an "Investor") severally listed on the Schedule of Investors attached hereto as Exhibit A, and Seahawk Capital Partners, Inc., as collateral agent on behalf of the Investors (the "Collateral Agent"). RECITALS A. WHEREAS, the Company has issued and sold 5% Secured Convertible Promissory Notes (the "Notes") to the Investors pursuant to the terms of that certain Senior Secured Convertible Promissory Note Purchase Agreement dated as of December 20, 2010 by and among the Company, the Investors named therein and the Collateral Agent, a
SENIOR SECURED CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENT by and among KiOR, Inc., KiOR Columbus, LLC, the Purchasers party hereto and the Agent October 18, 2013Senior Secured Convertible Promissory Note Purchase Agreement • October 21st, 2013 • Kior Inc • Industrial organic chemicals • New York
THIS SUBORDINATION AGREEMENT dated as of October [ ], 2013 is entered into by and among KiOR, INC., a Delaware corporation (the “Parent”), each other Grantor (as defined below) from time to time party hereto, Khosla Ventures III LP, in its capacity as administrative agent under the First-Lien Credit Documents (as defined below) (together with its successors and assigns in such capacity from time to time, the “First-Lien Agent”), 1538731 Alberta Ltd. , in its capacity as second-lien agent under the Second-Lien Loan Documents (as defined below) (together with its successors and assigns in such capacities from time to time, the “Second-Lien Agent”). Capitalized terms used herein but not otherwise defined herein have the meanings set forth in Section 1 below.
